Molecular and Cellular Biology

Wrestling with “next generation sequencing," a new molecular registry of tumors is helping Duke oncologists deliver patient- centered precision cancer medicine.

Duke Cancer Institute and Rice University researchers have identified a network of regulatory genes in sarcoma patients that seem to predict better outcomes.